ABBV vs. PFE
Compare and contrast key facts about AbbVie Inc. (ABBV) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABBV or PFE.
Performance
ABBV vs. PFE - Performance Comparison
Returns By Period
In the year-to-date period, ABBV achieves a 11.42% return, which is significantly higher than PFE's -7.49% return. Over the past 10 years, ABBV has outperformed PFE with an annualized return of 14.14%, while PFE has yielded a comparatively lower 2.59% annualized return.
ABBV
11.42%
-11.80%
4.00%
24.84%
19.06%
14.14%
PFE
-7.49%
-12.77%
-9.49%
-11.16%
-2.76%
2.59%
Fundamentals
| ABBV | PFE | |
|---|---|---|
| Market Cap | $293.84B | $148.42B |
| EPS | $2.87 | $0.75 |
| PE Ratio | 57.94 | 34.92 |
| PEG Ratio | 0.39 | 0.69 |
| Total Revenue (TTM) | $55.53B | $60.11B |
| Gross Profit (TTM) | $42.72B | $36.84B |
| EBITDA (TTM) | $25.57B | $15.48B |
Key characteristics
| ABBV | PFE | |
|---|---|---|
| Sharpe Ratio | 1.07 | -0.45 |
| Sortino Ratio | 1.40 | -0.49 |
| Omega Ratio | 1.24 | 0.94 |
| Calmar Ratio | 1.30 | -0.20 |
| Martin Ratio | 4.41 | -1.32 |
| Ulcer Index | 5.63% | 8.29% |
| Daily Std Dev | 23.17% | 24.48% |
| Max Drawdown | -45.09% | -54.82% |
| Current Drawdown | -18.30% | -53.07% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between ABBV and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
ABBV vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABBV vs. PFE - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 3.72%, less than PFE's 6.69% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.72% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% | 3.03% |
PFE Pfizer Inc. | 6.69% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% | 3.14% |
Drawdowns
ABBV vs. PFE - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum PFE drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for ABBV and PFE. For additional features, visit the drawdowns tool.
Volatility
ABBV vs. PFE - Volatility Comparison
AbbVie Inc. (ABBV) has a higher volatility of 15.66% compared to Pfizer Inc. (PFE) at 6.94%. This indicates that ABBV's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABBV vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities